IDEAYA Biosciences, Inc.
NASDAQ:IDYA
18.96 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 84.378 | 157.018 | 68.632 | 92.046 | 72.037 | 34.067 | 20.505 | 5.961 |
| Short Term Investments
| 591.941 | 368.096 | 296.197 | 154.724 | 211.548 | 64.889 | 69.456 | 7.196 |
| Cash and Short Term Investments
| 676.319 | 525.114 | 373.146 | 368.063 | 283.585 | 100.482 | 89.961 | 13.157 |
| Net Receivables
| 0.003 | 0.018 | 0.211 | 1.103 | 1.877 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -8.317 | -121.293 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 13.391 | 7.5 | 5.414 | 6.246 | 6.286 | 5.396 | 0.706 | 0.419 |
| Total Current Assets
| 689.713 | 532.632 | 370.454 | 250.996 | 288.605 | 100.482 | 90.667 | 13.576 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 27.741 | 8.41 | 8.993 | 8.661 | 9.476 | 9.699 | 5.152 | 3.743 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 107.492 | 8.317 | 121.293 | 0.106 | 1.526 | 0.106 | 0.071 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 406.637 | 0.782 | 0.205 | 0.397 | 0.082 | 1.294 | 0.616 | 0.089 |
| Total Non-Current Assets
| 434.378 | 116.684 | 17.515 | 130.351 | 9.664 | 12.519 | 5.874 | 3.903 |
| Total Assets
| 1,124.091 | 649.316 | 387.969 | 381.347 | 298.269 | 113.001 | 96.541 | 17.479 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 15.421 | 6.598 | 4.28 | 2.1 | 0.953 | 0.709 | 1.417 | 0.662 |
| Short Term Debt
| 0.596 | 1.747 | 3.742 | 3.398 | 3.08 | 1.145 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 8.568 | 29.04 | 27.613 | 5.023 | 0.299 | 0.297 |
| Other Current Liabilities
| 30.054 | 18.756 | 25.008 | 17.271 | 6.994 | 5.086 | 3.697 | 1.475 |
| Total Current Liabilities
| 46.071 | 27.101 | 31.718 | 45.159 | 38.64 | 6.94 | 5.413 | 2.434 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 18.873 | 1.125 | 1.611 | 3.482 | 5.183 | 0 | 0 | 3.207 |
| Deferred Revenue Non-Current
| 0 | 0 | 5.185 | 31.192 | 56.16 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -5.185 | -31.192 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0.012 | 5.661 | 140.076 | 27.577 |
| Total Non-Current Liabilities
| 18.873 | 1.125 | 6.796 | 34.674 | 61.355 | 5.661 | 140.076 | 30.784 |
| Total Liabilities
| 64.944 | 28.226 | 387.969 | 381.347 | 298.269 | 113.001 | 145.489 | 33.218 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 113.001 | 138.391 | 26.084 |
| Common Stock
| 0.009 | 0.007 | 0.005 | 0.004 | 0.003 | 0.002 | 0.001 | 0.001 |
| Retained Earnings
| -622.841 | -348.364 | -235.403 | -176.748 | -126.986 | -92.491 | -50.516 | -16.17 |
| Accumulated Other Comprehensive Income/Loss
| 0.812 | 0.562 | -2.871 | -0.712 | 0.007 | 0.065 | -0.031 | -0.001 |
| Other Total Stockholders Equity
| 1,681.167 | 968.885 | 587.724 | 478.97 | 325.25 | 192.824 | -136.792 | -26.084 |
| Total Shareholders Equity
| 1,059.147 | 621.09 | 349.455 | 301.514 | 198.274 | 100.4 | -48.948 | -15.739 |
| Total Equity
| 1,059.147 | 621.09 | 349.455 | 301.514 | 198.274 | 100.4 | -48.948 | -15.739 |
| Total Liabilities & Shareholders Equity
| 1,124.091 | 649.316 | 387.969 | 381.347 | 298.269 | 113.001 | 96.541 | 17.479 |